FOLH1 and prostate cancer: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has emerged as a highly sensitive imaging modality for prostate cancer (PCa), outperforming conventional methods like CT, MRI, and bone scintigraphy.